Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease

Clinical Oral Investigations

Volumn 19, Issue 1, 2015, Pages 45-52

  Chaturvedi, Rashi ^a   Gupta, Mili ^a,b   Jain, Ashish ^a   Das, Tarun ^a   Prashar, Savita ^a  

^a PANJAB UNIVERSITY   (India)

^b NONE   (India)

Author keywords

Periodontitis; Phase I therapy; sCD40 ligand

Indexed keywords

BIOLOGICAL MARKER; CD40 LIGAND;

ADULT; CASE CONTROL STUDY; CHEMISTRY; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PERIODONTAL INDEX;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CD40 LIGAND; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX;

EID: 84894612228     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-014-1216-3     Document Type: Article

References (52)

1. Page RC, Kornman KS (1997) The pathogenesis of human periodontitis: an introduction. Periodontol 14:9–11
2. Offenbacher S (1996) Periodontal diseases: pathogenesis. Ann Periodontol 1:821–878
3. Azuma M (2006) Fundamental mechanisms of host immune responses to infection. J Periodont Res 41:361–373
4. Zhang X, Teng YTA (2003) The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med 14:237–252
5. Yamazaki K, Yoshie H, Seymour GJ (2003) T cell regulation of the immune response to infection in periodontal diseases. Histol Histopathol 18:889–896
6. Mathur A, Michalowicz BS (1997) Cell-mediated immune system regulation in periodontal diseases. Crit Rev Oral Biol Med 8:76–89
7. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357
8. Gately MK, Renzetti LM, Magram J et al (1998) The interleukin-12/interleukin-12- receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16:495–521
9. Grewal IS, Flavell RA (1996) A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 17:410–414
10. Lenschow DL, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233–258
11. Schonbeck U, Mach F, Libby P (2000) CD154 (CD 40 ligand). Int J Biochem Cell Biol 32:687–693
12. Clark LB, Foy TM, Noelle RJ (1996) CD40 and its ligand. Adv Immunol 63:43–78
13. Van Kooten C, Banchereau J (1996) CD 40- CD 40 ligand: a multifunctional receptor—ligand pair. Adv Immunol 61:1–77
14. Grewal IS, Flavell RA (1998) CD40 and CD 154 in cell mediated immunity. Annu Rev Immunol 16:111–135
15. Freedman JE (2003) CD40-CD40L and platelet function: beyond hemostasis. Circ Res 92:944–946
16. Phipps RP (2000) Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci U S A 97:6930–6932
17. Schonbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P (1997) Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signalling in plaque rupture ? Circ Res 81:448–454
18. Noel RJ (1996) CD40 and its ligand in host defence. Immunity 4:415–419
19. Zhou L, Stordeur P, de Lavareille A, Theilman K, Capel P, Goldman M et al (1998) CD40 engagement on endothelial cells promotes tissue factor dependent procoagulant activity. Thromb Haemostat 79:1025–1028
20. Paquette DW, Brodala N, Nichols TC (2007) Cardiovascular disease, inflammation, and periodontal infection. Periodontology 44:113–126
21. Herzberg MC, Weyer MW (1998) Dental plaque, platelets and cardiovascular disease. Ann Periodontol 3:151–160
22. Lockhart PB, Bolger AF, Papapanou PN et al (2012) Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation 125:2520–2544
23. Bahekar AA, Singh S, Saha S, Molnar J, Arora R (2007) The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154:830–837
24. Beck JD, Garcia R, Heiss G, Vokonas P, Offenbacher S (1996) Periodontal disease and cardiovascular disease. J Periodontol 67:1123–1137
25. Matilla KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL (1993) Dental infections and coronary atherosclerosis. Atherosclerosis 103:205–211
26. Aukrust P, Muller F, Ueland T et al (1999) Enhanced levels of soluble and membrane bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614–620
27. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM et al (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 349:1104–1111
28. Balla J, Magyar MT, Bereczki D, Valikovics A, Nagy E, Barna E et al (2006) Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease. Dis Markers 22:133–140
29. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM (2001) Soluble CD40L and cardiovascular risk in women. Circulation 104:2266–2268
30. Papapanagiotou D, Nicu EA, Bizzarro S et al (2009) Periodontitis is associated with platelet activation. Atherosclerosis 202:605–611
31. Marcaccini AM, Meschiari CA, Sorgi CA et al (2009) Circulating interleukin- 6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 80:594–602
32. Dongari- Bagtzoglou AI, Warren WD, Berton MT, Ebersole JL (1997) CD40 expression by gingival fibroblasts: correlation of phenotype with function. Int Immunol 9:1233–1241
33. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M (2004) CD40–CD40L expression during orthodontic tooth movement in rats. Angle Orthod 74:100–105
34. Sempowski GD, Chess PR, Moretti AJ, Padilla J, Phipps RP, Blieden TM (1997) CD40 mediated activation of gingival and PDL fibroblast. J Periodontol 68:284–292
35. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S (2003) Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 31:167–180
36. Loe SJ (1963) Periodontal disease in pregnancy. I. prevalence and severity. Acta Odontol Scand 21:533–551
37. Silness P, Loe H (1964) Periodontal disease in pregnancy. Acta Odontol Scand 22:121
38. Page RC, Eke PI (2007) Case definitions for use in population-based surveillance of periodontitis. J Periodontol 78:1387–1399
39. Harris EF, Smith RN (2009) Accounting for measurement error: a critical but often overlooked process. Archives of Oral Biol 54s:s107–s117
40. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86:306–319
41. Wassenaar A, Verschoor T, Kievits F, Den Hartog MT, Kapsenberg ML, Everts V, Snijders A (1999) CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts. Clin Exp Immunol 115:161–167
42. Reyes L, Herrera D, Kozarov E, Rold_an S, Progulske-Fox A (2013) Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Periodontol 84:S30–S50
43. Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE (2003) Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 71(10):6012–6018
44. Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109(21 Suppl 1):II2–II10
45. Bizzarro S, van der Velden U, ten Heggeler JMAG et al (2007) Periodontitis is characterized by elevated PAI-1 activity. J Clin Periodontol 34:574–580
46. Gupta M, Chaturvedi R, Jain A (2013) Role of monocyte chemoattractant protein-1(MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine 61(3):892–897
47. Wakai K, Kawamura T, Umemura O et al (1999) Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 26:664–672
48. Christan C, Dietrich T, Hagewald S, Kage A, Bernimoulin JP (2002) White blood cell count in generalized aggressive periodontitis after nonsurgical therapy. J Clin Periodontol 29:201–206
49. Andre P, Nannizzi-Alaimo L, Prasad DK, Phillips DR (2002) Platelet derived CD40L: the switch hitting player of cardiovascular disease. Circulation 106:896–899
50. Schenkein HA, Loos BG (2013) Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol 84:S51–S69
51. D’Aiuto F, Orlandi M, Gunsolley JC (2013) Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Periodontol 84:S85–S105
52. Tonetti MS, D’Aiuto F, Nibali L et al (2007) Treatment of periodontitis and endothelial function. N Engl J Med 356:911–920